<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03931096</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL19_0061</org_study_id>
    <nct_id>NCT03931096</nct_id>
  </id_info>
  <brief_title>Quality of Life Assessment of Children With Congenital Heart Disease Aged 5 to 7 Years</brief_title>
  <acronym>QoL-CHD-5-7</acronym>
  <official_title>Quality of Life Assessment of Children With Congenital Heart Disease Aged 5 to 7 Years : a Multicentre Controlled Cross-sectional Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pediatric and Congenital Cardiology Department of Necker-enfant malades University Hospital, Paris, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Congenital heart diseases (CHD) are the firt cause of congenital malformations (8 for 1000
      births). Since the 90's, great advances in prenatal diagnosis, pediatric cardiac surgery,
      intensive care, and cardiac catheterization have reduced morbidity and early mortality in
      this population. Prevalence of &quot; GUCH &quot;, grown-ups with congenital heart disease has thus
      been significantly increasing. Nowadays, quality of life (QoL) assessment of this population
      is in the foreground. Our team is a reference center in the management of patient with CHD,
      from the fetal period to adulthood. The investigators have been conducting a clinical
      research program on health related QoL in pediatric and congenital heart disease. The
      investigators thus demonstrated the link between cardiopulmonary fitness and QoL in children
      with CHD aged 8 to 18 years, the correlation between functional class and QoL in adults with
      CHD, and the impact of therapeutic education on QoL in children under anticoagulants.
      Currently, no controlled cross-sectional quality of life study assessment has been leaded in
      the youngest children with CHD. This present study therefore extends our work in younger
      children aged 5 to 7 years.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      248 patients will be enrolled in this study.

      Patient from groups 1 is included during his annual medical check-up. Quality of life
      questionnaire and other examinations are performed during this site visit. Its is a part of
      his usual care. No supplementary visit, directly related to the research, are necessary. 2
      sites will participate to the enrollment, belonging to the French national network for
      complex congenital heart diseases (M3C) .

      Participants (healthy children) from groups 2 are included from schools.The prior agreement
      of the Ministry of National Education was obtained before any procedure related to this
      study. 3 schools will participate to the enrolment
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2019</start_date>
  <completion_date type="Actual">December 31, 2019</completion_date>
  <primary_completion_date type="Actual">December 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>score of the self QoL questionnaire (PedsQL 4.0 : Pediatric Quality of Life Inventory Version 4.0 Generic Core Scales)</measure>
    <time_frame>1 day</time_frame>
    <description>Comparison of the total score of the self QoL questionnaire (PedsQL 4.0 : Pediatric Quality of Life Inventory Version 4.0 Generic Core Scales) between patients with CHD and control children recruited in schools, aged 5 to 7 years. The self QoL questionnaire PedsQL 4.0 is composed of 23 items comprising 4 dimensions. Items are reversed scored and linearly transformed to a 0-100 scale. In order to get a total score we must sum all the items scores over the number of items answered on all the Scales. If more than 50% of the items in the scale are missing, the scale scores should not be computed.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>score of proxy QoL questionnaire (PedsQL 4.0 : Pediatric Quality of Life Inventory Version 4.0 Generic Core Scales)</measure>
    <time_frame>1 day</time_frame>
    <description>Comparison of the total score of proxy QoL questionnaire (PedsQL 4.0 : Pediatric Quality of Life Inventory Version 4.0 Generic Core Scales) between patients with CHD and schoolchildren aged 5 to 7 years. The proxy QoL questionnaire PedsQL 4.0 is composed of 23 items comprising 4 dimensions. Items are reversed scored and linearly transformed to a 0-100 scale. In order to get a total score we must sum all the items scores over the number of items answered on all the Scales. If more than 50% of the items in the scale are missing, the scale scores should not be computed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>score by dimensions of self and proxy QoL questionnaire (PedsQL 4.0 : Pediatric Quality of Life Inventory Version 4.0 Generic Core Scales)</measure>
    <time_frame>1 day</time_frame>
    <description>Comparison of score by dimensions of self and proxy QoL questionnaire (PedsQL 4.0 : Pediatric Quality of Life Inventory Version 4.0 Generic Core Scales) between patients with CHD and schoolchildren aged 5 to 7 years.The proxy QoL questionnaire PedsQL 4.0 is composed of 23 items comprising 4 dimensions. Items are reversed scored and linearly transformed to a 0-100 scale. In order o get score by dimensions of scale we must sum the items scores over the number of items answered. If more than 50% of the items in the scale are missing, the scale scores should not be computed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>score of QoL questionnaire (PedsQL 4.0 : Pediatric Quality of Life Inventory Version 4.0 Generic Core Scales) to the type of the CHD using the ACC-CHD classification.</measure>
    <time_frame>1 day</time_frame>
    <description>Comparison of score of QoL questionnaire (PedsQL 4.0 : Pediatric Quality of Life Inventory Version 4.0 Generic Core Scales) to the type of the CHD using the ACC-CHD classification. The QoL questionnaire PedsQL 4.0 is composed of 23 items comprising 4 dimensions. Items are reversed scored and linearly transformed to a 0-100 scale. In order to get a total score we must sum all the items scores over the number of items answered on all the Scales. If more than 50% of the items in the scale are missing, the scale scores should not be computed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>score of QoL questionnaire (PedsQL 4.0 : Pediatric Quality of Life Inventory Version 4.0 Generic Core Scales) to the severity of the CHD using the BETHESDA classification.</measure>
    <time_frame>1 day</time_frame>
    <description>Comparison of score of QoL questionnaire (PedsQL 4.0 : Pediatric Quality of Life Inventory Version 4.0 Generic Core Scales) to the severity of the CHD using the BETHESDA classification. The QoL questionnaire PedsQL 4.0 is composed of 23 items comprising 4 dimensions. Items are reversed scored and linearly transformed to a 0-100 scale. In order to get a total score we must sum all the items scores over the number of items answered on all the Scales. If more than 50% of the items in the scale are missing, the scale scores should not be computed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>score of QoL questionnaire (PedsQL 4.0 : Pediatric Quality of Life Inventory Version 4.0 Generic Core Scales) to the patient functional status using the Ross classification.</measure>
    <time_frame>1 day</time_frame>
    <description>Comparison of score of QoL questionnaire (PedsQL 4.0 : Pediatric Quality of Life Inventory Version 4.0 Generic Core Scales) to the patient functional status using the Ross classification. The QoL questionnaire PedsQL 4.0 is composed of 23 items comprising 4 dimensions. Items are reversed scored and linearly transformed to a 0-100 scale. In order to get a total score we must sum all the items scores over the number of items answered on all the Scales. If more than 50% of the items in the scale are missing, the scale scores should not be computed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>score of QoL questionnaire (PedsQL 4.0 : Pediatric Quality of Life Inventory Version 4.0 Generic Core Scales) to the prognostic classification of the CHD using Davey B.T classification.</measure>
    <time_frame>1 day</time_frame>
    <description>Comparison of score of QoL questionnaire (PedsQL 4.0 : Pediatric Quality of Life Inventory Version 4.0 Generic Core Scales) to the prognostic classification of the CHD using Davey B.T. The QoL questionnaire PedsQL 4.0 is composed of 23 items comprising 4 dimensions. Items are reversed scored and linearly transformed to a 0-100 scale. In order to get a total score we must sum all the items scores over the number of items answered on all the Scales. If more than 50% of the items in the scale are missing, the scale scores should not be computed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>impact of variables related to the patient and to the CHD on his quality of life with the scores of QoL questionnaire (PedsQL 4.0 : Pediatric Quality of Life Inventory Version 4.0 Generic Core Scales)</measure>
    <time_frame>1 day</time_frame>
    <description>Study of the association of the following variables related to the patient and to the CHD with the scores of QoL questionnaire (PedsQL 4.0 : Pediatric Quality of Life Inventory Version 4.0 Generic Core Scales) . Univariate end multivariate analysis will be performed. The variables are:
sex of the patient,
age at diagnosis of CHD (pre or post natal)
number of cardiac surgeries
type of cardiac surgery (thoracotomy or sternotomy)
number of cardiac catheterizations
type of medical treatment
left ventricular ejection fraction (LVEF)
the presence of pulmonary arterial hypertension
the presence of a mechanical valve
the presence of a pacemaker or defibrillator
the presence of hypertension of the right ventricle.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychometric properties of the QoL questionnaire (PedsQL 4.0 : Pediatric Quality of Life Inventory Version 4.0 Generic Core Scales) .</measure>
    <time_frame>1 day</time_frame>
    <description>Evaluation of the psychometric properties of the QoL questionnaire (PedsQL 4.0 : Pediatric Quality of Life Inventory Version 4.0 Generic Core Scales) .The Pediatric Quality of Life Inventory Version 4.0 (PedsQLTM 4.0) is a questionnaire widely used in pediatric clinical trials. This questionnaire was translated and linguistically validated in French, but no complete psychometric validation for French children has been performed yet. Reliability and validity are considered the main measurement properties of such instruments.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">248</enrollment>
  <condition>Congenital Heart Disease</condition>
  <arm_group>
    <arm_group_label>children with congenital heart disease</arm_group_label>
    <description>Groupe 1: case: children with congenital heart disease aged 5 to 7 years.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control children</arm_group_label>
    <description>Groupe 2: control children recruited in schools aged 5 to 7 years.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Quality of life questionnaire</intervention_name>
    <description>Self and proxy PedsQL 4.0 questionnaires.</description>
    <arm_group_label>children with congenital heart disease</arm_group_label>
    <arm_group_label>control children</arm_group_label>
    <other_name>Quality of life questionnaire: Pediatric Quality of Life Inventory Version 4.0 (PedsQL 4.0).</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Groups 1 : Children with congenital heart disease aged 5 to 7 years Groups 2 : Healthy
        children aged 5 to 7 years
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

        â€¢ Children with CHD (as defined in the ACC-CHD classification) aged 5 to 7 years or same
        aged school children.

        Exclusion criteria:

          -  Other comorbidity affecting quality of life (polymalformative syndrome, extracardiac
             organ failure, neurodegenerative disease, severe genetic disease, psychomotor
             retardation).

          -  Surgical procedure during the last 6 months.

          -  Inability to understand the QoL questionnaire (parents and / or child): non-french
             speaker, severe intellectual disability.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>7 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pascal AMEDRO, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Uhmontpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>April 8, 2019</study_first_submitted>
  <study_first_submitted_qc>April 24, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 30, 2019</study_first_posted>
  <last_update_submitted>March 9, 2020</last_update_submitted>
  <last_update_submitted_qc>March 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>health related quality of life</keyword>
  <keyword>congenital heart disease</keyword>
  <keyword>pediatrics</keyword>
  <keyword>cardiology</keyword>
  <keyword>PedsQL 4.0</keyword>
  <keyword>psychometric properties</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Defects, Congenital</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>NC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

